Page last updated: 2024-10-25

chlorpropamide and Metabolic Diseases

chlorpropamide has been researched along with Metabolic Diseases in 2 studies

Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.

Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Richards, P1
Hodkinson, HM1

Other Studies

2 other studies available for chlorpropamide and Metabolic Diseases

ArticleYear
Drug-induced metabolic disease.
    British medical journal, 1979, Apr-28, Volume: 1, Issue:6171

    Topics: Anti-Inflammatory Agents; Antidepressive Agents; Chlorpropamide; Diabetes Mellitus; Diuretics; Gout;

1979
Biochemical side effects of drugs in the elderly.
    Gerontologia clinica, 1974, Volume: 16, Issue:1

    Topics: Aged; Calcium; Chlorpropamide; Diethylstilbestrol; Drug-Related Side Effects and Adverse Reactions;

1974